A Hospital Acquired Infection (HAI) is an infection that develops during the course of a hospital stay. People who are in hospital are at greater risk of developing infections for a variety of reasons.
These include:
- a weakened immune system;
- increased use of antibiotics;
- surgical and medical procedures that cause breaks in the skin; and
- transmission of bacteria from one person to another due to close contact with other patients and healthcare workers.
The Infection Prevention and Control program monitors for infections throughout the organization as a part of ongoing initiatives to improve patient safety.
Several patient safety indicators that are tracked and reported on a quarterly basis by Eastern Health include:
Surveillance Statistics for HAIs
Infections and Rates
Fiscal Year 2019-20
|
Clostridium difficile:
|
|
Acute Care
Cases |
Rate per
10,000
pt days |
LTC Cases |
Rate per
10,000
pt days |
| Q1 (April-June) 2019-20 |
11 |
1.56 |
2 |
0.14 |
|
Methicillin Resistant Staphylococcus Aureus (MRSA):
|
|
|
Acute Care
Cases
|
Rate per
10,000
pt days
|
LTC Cases
|
Rate per
10,000
pt days
|
| Q1 (April-June) 2019-20 |
18 |
2.55 |
3 |
0.21 |
Infections and Rates
Fiscal Year 2017-18
|
Clostridium difficile:
|
|
Acute Care
Cases |
Rate per
10,000
pt days |
LTC Cases |
Rate per
10,000
pt days |
| Q2 (July-September) 2017-18 |
16 |
2.38 |
1 |
0.07 |
| *Q1 (April-June) 2017-18 |
22 |
3.15 |
2 |
0.14 |
|
Methicillin Resistant Staphylococcus Aureus (MRSA):
|
|
|
Acute Care
Cases
|
Rate per
10,000
pt days
|
LTC Cases
|
Rate per
10,000
pt days
|
| Q2 (July-September) 2017-18 |
16 |
2.78 |
5 |
0.34 |
|
*Q1 (April-June) 2017-18
|
13
|
1.86
|
2
|
0.14
|
Infections and Rates
Fiscal Year 2016-17
|
Clostridium difficile:
|
|
Acute Care
Cases |
Rate per
10,000
pt days |
LTC Cases |
Rate per
10,000
pt days |
| Q4 (Jan.-March) 2017 |
34 |
4.59 |
8 |
0.56 |
| *Q3 (Oct.-Dec.) 2016-17 |
22 |
3.07 |
4 |
0.27 |
| *Q2 (July-Sept.) 2016-17 |
15 |
2.15 |
6 |
0.41 |
| *Q1 (April-June) 2016-17 |
17 |
2.36 |
2 |
0.14 |
|
Methicillin Resistant Staphylococcus Aureus (MRSA):
|
|
|
Acute Care
Cases
|
Rate per
10,000
pt days
|
LTC Cases
|
Rate per
10,000
pt days
|
|
Q4 (Jan.-March) 2017
|
19
|
2.57
|
2
|
0.14
|
| *Q3 (Oct.-Dec.) 2016-17 |
17 |
2.37 |
3 |
0.20 |
|
*Q2 (July-Sept.) 2016-17
|
12
|
1.72
|
7
|
0.47
|
|
*Q1 (April-June) 2016-17
|
10
|
1.39
|
4
|
0.27
|
Infections and Rates
Fiscal Year 2015-16
|
Clostridium difficile:
|
|
Acute Care
Cases |
Rate per
10,000
pt days |
LTC Cases |
Rate per
10,000
pt days |
| *Q4 (Jan.-Mar.) 2016 |
23 |
3.19 |
10 |
0.69 |
| Q3 (Oct.-Dec.) 2015-16 |
19 |
2.81 |
5 |
0.30 |
| Q2 (July-Sept.) 2015-16 |
17 |
2.48 |
4 |
0.28 |
| Q1 (April-June) 2015-16 |
33 |
4.71 |
7 |
0.50 |
|
Methicillin Resistant Staphylococcus Aureus (MRSA):
|
|
|
Acute Care
Cases
|
Rate per
10,000
pt days
|
LTC Cases
|
Rate per
10,000
pt days
|
|
*Q4 (Jan.-Mar.) 2016
|
22 |
3.05 |
6 |
0.41 |
|
Q3 (Oct.-Dec.) 2015-16
|
15 |
2.22 |
5 |
0.74 |
|
Q2 (July-Sept.) 2015-16
|
15
|
2.19
|
12
|
0.83
|
|
Q1 (April-June) 2015-16
|
32
|
4.56
|
8
|
0.57
|
Infections and Rates
|
Clostridium difficile:
|
|
Acute Care
Cases |
Rate per
10,000
pt days |
LTC Cases |
Rate per
10,000
pt days |
| Q1 2014-15 |
20 |
2.64 |
4 |
0.28 |
| Q2 2014-15 |
18 |
2.47 |
3 |
0.21 |
| Q3 2014-15 |
31 |
4.16 |
8 |
0.54 |
| Q4 2014-15 |
33 |
4.46 |
8 |
0.56 |
|
Methicillin Resistant Staphylococcus Aureus (MRSA):
|
|
|
Acute Care
Cases
|
Rate per
10,000
pt days
|
LTC Cases
|
Rate per
10,000
pt days
|
|
Q1 2014-15
|
28
|
3.70
|
5
|
0.35
|
|
Q2 2014-15
|
43
|
5.90
|
9
|
0.63
|
|
Q3 2014-15
|
22
|
2.95
|
5
|
0.34
|
|
Q4 2014-15
|
21
|
2.84
|
4
|
0.28
|
pt: patient
*: Numbers updated based on new data.
|
 |
|